Literature DB >> 12437710

Convulsions following axillary brachial plexus blockade with levobupivacaine.

D Pirotta1, J Sprigge.   

Abstract

Neurotoxicity manifesting as convulsions is a recognised complication of the administration of local anaesthetic drugs as part of a regional anaesthetic technique. We describe a case of self-limiting convulsions following the institution of an axillary brachial plexus block with levobupivacaine. Although the occurrence of convulsions following the administration of racemic bupivacaine is a well-recognised complication, there have been no clinical case reports published describing convulsions following the use of levobupivacaine in regional anaesthesia.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12437710     DOI: 10.1046/j.1365-2044.2002.02860.x

Source DB:  PubMed          Journal:  Anaesthesia        ISSN: 0003-2409            Impact factor:   6.955


  5 in total

Review 1.  [Levobupivacaine for regional anesthesia. A systematic review].

Authors:  B Urbanek; S Kapral
Journal:  Anaesthesist       Date:  2006-03       Impact factor: 1.041

2.  Safety and Pharmacokinetics of Levobupivacaine Following Fascia Iliaca Compartment Block in Elderly Patients.

Authors:  Peter M Odor; Alison G Cavalier; Neal D Reynolds; King S Ang; Simon J Parrington; Hua Xu; Atholl Johnston; Frederic J Sage
Journal:  Drugs Aging       Date:  2019-06       Impact factor: 3.923

Review 3.  Clinical Pharmacokinetics and Pharmacodynamics of Levobupivacaine.

Authors:  Chantal A A Heppolette; Derek Brunnen; Sohail Bampoe; Peter M Odor
Journal:  Clin Pharmacokinet       Date:  2020-06       Impact factor: 6.447

4.  Safety Evaluation of EXPAREL (DepoFoam Bupivacaine) Administered by Repeated Subcutaneous Injection in Rabbits and Dogs: Species Comparison.

Authors:  Brigitte M Richard; Douglas E Rickert; Paul E Newton; Laura R Ott; Dean Haan; Abram N Brubaker; Phaedra I Cole; Paul E Ross; Marlon C Rebelatto; Keith G Nelson
Journal:  J Drug Deliv       Date:  2011-10-05

5.  Update on local anesthetics: focus on levobupivacaine.

Authors:  Crina L Burlacu; Donal J Buggy
Journal:  Ther Clin Risk Manag       Date:  2008-04       Impact factor: 2.423

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.